AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 60(1), 1999, pp. 94-98
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lejon, V
Right arrow Articles by Sema, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lejon, V
Right arrow Articles by Sema, H.
Related Collections
Right arrow Pathogenesis
American Journal of Tropical Medicine and Hygiene, Vol 60, Issue 1, 94-98
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients

V Lejon, LE Rosengren, P Buscher, JE Karlsson, and HN Sema

Light subunit neurofilament (NFL) and glial fibrillary acidic protein (GFAP) concentrations were determined in cerebrospinal fluid (CSF) of 34 patients with human African trypanosomiasis (HAT), five serologically positive but parasitologically unconfirmed individuals, and four healthy controls without evidence of HAT. In patients with second stage HAT (n = 30), NFL levels were abnormally elevated in 10 cases and GFAP levels in five. The astrogliosis observed in HAT and experimental models of HAT is confirmed in our study by the presence of increased GFAP levels in the CSE The abnormal NFL CSF levels reflect structural damage of nerve cells in 33 % of the second-stage patients studied. To our knowledge, this is the first time neuronal damage in HAT patients is demonstrated by using biochemical markers of brain damage in the CSF.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
J. L. Kadurugamuwa, K. Modi, O. Coquoz, B. Rice, S. Smith, P. R. Contag, and T. Purchio
Reduction of Astrogliosis by Early Treatment of Pneumococcal Meningitis Measured by Simultaneous Imaging, In Vivo, of the Pathogen and Host Response
Infect. Immun., December 1, 2005; 73(12): 7836 - 7843.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
F. Chappuis, L. Loutan, P. Simarro, V. Lejon, and P. Buscher
Options for Field Diagnosis of Human African Trypanosomiasis
Clin. Microbiol. Rev., January 1, 2005; 18(1): 133 - 146.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Petzold, M. J. Eikelenboom, D. Gveric, G. Keir, M. Chapman, R. H. C. Lazeron, M. L. Cuzner, C. H. Polman, B. M. J. Uitdehaag, E. J. Thompson, et al.
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
Brain, July 1, 2002; 125(7): 1462 - 1473.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.